Market revenue in 2023 | USD 2,190.6 million |
Market revenue in 2030 | USD 2,210.1 million |
Growth rate | 0.1% (CAGR from 2023 to 2030) |
Largest segment | Immunoturbidimetric assay |
Fastest growing segment | Other Assay Types |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoturbidimetric Assay, Chemiluminescence Immunoassay, Other Assay Types, ELISA |
Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG ADR, Danaher Corp, Quest Diagnostics Inc, Siemens Healthineers AG ADR, Abbott Laboratories, Merck KGaA, Zoetis Inc Class A, QuidelOrtho Corp, Horiba Ltd, Getein Biotech, Boditech Med, Randox, Aidian |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to c-reactive protein testing market will help companies and investors design strategic landscapes.
Immunoturbidimetric assay was the largest segment with a revenue share of 48.46% in 2023. Horizon Databook has segmented the North America c-reactive protein testing market based on immunoturbidimetric assay, chemiluminescence immunoassay, other assay types, elisa covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounted for the largest market share in 2020. This can be attributed to various factors such as well-established healthcare infrastructure, supportive government policies, and high R&D investments in the region.
In addition, rising incidence of chronic heart diseases and cancers is also one of the major factors responsible for the market growth. Presence of organization such as American College of Cardiology Foundation and similar ones, drives awareness amongst the users for adoption of the test for the preliminary screening of various inflammatory disorder.
These organizations release news bulletins and carry out awareness campaigns across social media and the private organizations under employee screening schemes. Some of the other key factors boosting the market are local presence of major market players, easy availability of various testing kits & reagents, and growing awareness among people about early disease testing & screening.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America c-reactive protein testing market , including forecasts for subscribers. This continent databook contains high-level insights into North America c-reactive protein testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account